Behavidence Israel

AI-based digital phenotyping to measure and monitor mental health from smartphone behavior.

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in February 2025, Behavidence Israel operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI-based digital phenotyping technology.

Business overview

Behavidence Israel develops an AI-driven digital mental health measurement and monitoring solution. Its core technology generates daily behavioral scores by analyzing passive smartphone usage patterns. The platform is designed for screening and remote monitoring of conditions such as depression, anxiety, stress, and ADHD. It can be deployed as a standalone application or integrated via an SDK into partner products, serving healthcare providers, insurers, researchers, and organizations requiring continuous, low-burden, and privacy-focused mental health tracking within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Behavidence Israel's primary focus?
Behavidence Israel focuses on AI-based digital phenotyping to measure and monitor mental health using smartphone behavior patterns.
When was Behavidence Israel founded?
Behavidence Israel was founded in February 2025.
What kind of technology does Behavidence Israel utilize?
Behavidence Israel utilizes AI to analyze passive smartphone usage patterns, generating daily behavioral scores for mental health assessment.
Which sectors does Behavidence Israel operate in?
Behavidence Israel operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring.